China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

NYSE CPHI opened at $0.24 on Friday. China Pharma has a one year low of $0.13 and a one year high of $0.44. The company has a 50-day simple moving average of $0.22 and a 200-day simple moving average of $0.22. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Read More

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.